Specifically designed for immunological research, particularly in exploring the Structure-Activity Relationship (SAR) of the TLR4 receptor.Compared to the potent 6-acyl (6A) version, the 3A variant exhibits minimal activity in human immune cells and possesses potential antagonistic properties. It serves as a promising candidate for therapeutic drug development in autoimmune and allergic diseases.Quality level: Research grade _x000D_